Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines

This publication has 26 references indexed in Scilit:

• Combined modality treatment for carcinomas of the uterine cervix and vulva
  Current Opinion in Oncology, 1994
• Differential modulation of radiosensitivity following induction ofcis-platinum resistance in radiation-sensitive and radiation-resistant human tumor cells
  Radiation Oncology Investigations, 1994
• De novo cisplatinum resistance does not influence cellular radiosensitivity
  European Journal Of Cancer, 1993
• The differential induction of collateral resistance to 62.5 MeV (p→Be+) neutrons and 4 MeV photons by exposure to cis-platinum
  International Journal of Radiation Oncology*Biology*Physics, 1993
• BSO-induced reduction of glutathione levels increases the cellular radiosensitivity of drug-resistant human tumor cells
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Collateral resistance to photon and neutron irradiation is associated with acquired cis-platinum resistance in human ovarian tumour cells
  Radiotherapy and Oncology, 1992
• Inherent radio sensitivity testing of tumor biopsies obtained from patients with carcinoma of the cervix or endometrium
  Radiotherapy and Oncology, 1991
• Potentiation of radiotherapy by Cis-dichlorodiammine platinum (II) in advanced cervical carcinoma
  Gynecologic Oncology, 1986
• Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1985
• The radioresponsiveness of human tumours and the initial slope ofthe cell survival curve
  Radiotherapy and Oncology, 1984